Log in

OTCMKTS:KHRNFKhiron Life Sciences Stock Price, Forecast & News

-0.06 (-9.98 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: $0.54
50-Day Range
MA: $0.48
52-Week Range
Now: $0.54
Volume259,489 shs
Average Volume217,979 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Khiron Life Sciences Corp. develops cannabis products for medical purposes. It also provides cosmeceutical and nutraceutical products. The company was founded in 2017 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.44 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive KHRNF News and Ratings via Email

Sign-up to receive the latest news and ratings for KHRNF and its competitors with MarketBeat's FREE daily newsletter.

Khiron Life Sciences (OTCMKTS:KHRNF) Frequently Asked Questions

How has Khiron Life Sciences' stock been impacted by COVID-19 (Coronavirus)?

Khiron Life Sciences' stock was trading at $0.4259 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, KHRNF shares have increased by 27.1% and is now trading at $0.5415. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Khiron Life Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Khiron Life Sciences.

What price target have analysts set for KHRNF?

1 brokers have issued twelve-month price objectives for Khiron Life Sciences' stock. Their forecasts range from $2.80 to $2.80. On average, they anticipate Khiron Life Sciences' share price to reach $2.80 in the next year. This suggests a possible upside of 417.1% from the stock's current price. View analysts' price targets for Khiron Life Sciences.

Has Khiron Life Sciences been receiving favorable news coverage?

Press coverage about KHRNF stock has trended negative recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Khiron Life Sciences earned a news sentiment score of -2.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutKhiron Life Sciences.

Who are some of Khiron Life Sciences' key competitors?

Who are Khiron Life Sciences' key executives?

Khiron Life Sciences' management team includes the following people:
  • Mr. Alvaro Francisco Torres, Founder, CEO & Director (Age 40)
  • Mr. Andres Galofre, Co-founder & VP of Bus. Devel.s (Age 37)
  • Mr. Darren Collins, CFO & Corp. Sec. (Age 36)
  • Dr. Paulo Vega, VP of Medical (Age 54)
  • Mr. Chris Naprawa, Pres (Age 48)

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF."

How do I buy shares of Khiron Life Sciences?

Shares of KHRNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Khiron Life Sciences' stock price today?

One share of KHRNF stock can currently be purchased for approximately $0.54.

What is Khiron Life Sciences' official website?

The official website for Khiron Life Sciences is www.khiron.ca.

How can I contact Khiron Life Sciences?

The company can be reached via phone at 705-527-3564.

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.